Tacatuzumab tetraxetan

WikiDoc Resources for Tacatuzumab tetraxetan
Articles
Most recent articles on Tacatuzumab tetraxetan Most cited articles on Tacatuzumab tetraxetan Review articles on Tacatuzumab tetraxetan Articles on Tacatuzumab tetraxetan in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tacatuzumab tetraxetan Images of Tacatuzumab tetraxetan Photos of Tacatuzumab tetraxetan Podcasts & MP3s on Tacatuzumab tetraxetan Videos on Tacatuzumab tetraxetan
Evidence Based Medicine
Cochrane Collaboration on Tacatuzumab tetraxetan Bandolier on Tacatuzumab tetraxetan TRIP on Tacatuzumab tetraxetan
Clinical Trials
Ongoing Trials on Tacatuzumab tetraxetan at Clinical Trials.gov Trial results on Tacatuzumab tetraxetan Clinical Trials on Tacatuzumab tetraxetan at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tacatuzumab tetraxetan NICE Guidance on Tacatuzumab tetraxetan NHS PRODIGY Guidance FDA on Tacatuzumab tetraxetan CDC on Tacatuzumab tetraxetan
Books
Books on Tacatuzumab tetraxetan
News
Tacatuzumab tetraxetan in the news Be alerted to news on Tacatuzumab tetraxetan News trends on Tacatuzumab tetraxetan
Commentary
Blogs on Tacatuzumab tetraxetan
Definitions
Definitions of Tacatuzumab tetraxetan
Patient Resources / Community
Patient resources on Tacatuzumab tetraxetan Discussion groups on Tacatuzumab tetraxetan Patient Handouts on Tacatuzumab tetraxetan Directions to Hospitals Treating Tacatuzumab tetraxetan Risk calculators and risk factors for Tacatuzumab tetraxetan
Healthcare Provider Resources
Symptoms of Tacatuzumab tetraxetan Causes & Risk Factors for Tacatuzumab tetraxetan Diagnostic studies for Tacatuzumab tetraxetan Treatment of Tacatuzumab tetraxetan
Continuing Medical Education (CME)
CME Programs on Tacatuzumab tetraxetan
International
Tacatuzumab tetraxetan en Espanol Tacatuzumab tetraxetan en Francais
Business
Tacatuzumab tetraxetan in the Marketplace Patents on Tacatuzumab tetraxetan
Experimental / Informatics
List of terms related to Tacatuzumab tetraxetan

Overview

Tacatuzumab tetraxetan is a humanized monoclonal antibody used to treat cancer. Tacatuzumab has a chelator, tetraxetan. It has a radioisotope, yttrium-90Y.